Nestlé, the world’s largest food company, is rumoured to be in negotiations to purchase baby food company Gerber Products from Swiss drug maker Novartis in a deal thought to be worth as much as US$5bn. However, the food giant has declined to respond to the reports.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Nestlé is already in negotiations with Novartis over the purchase of a medical-nutrition business. Nestlé is keen to make the acquisition of Gerber part of the same deal, a report in the Wall Street Journal said, citing sources familiar with the situation.
Nestlé was declined to comment on the report, while Novartis confirmed to just-food that it has received offers for the baby food business, but declined to provide further detail.
